Hepatitis B surface antigen (HBsAg) prevalence in Libya
Libya: Hepatitis B surface antigen (HBsAg) prevalence was 0.2% in 2024. ▬ Flat
Latest (2024)
0.2%
Change on year
unchanged
World rank
82nd
of 194 countries
All-time high
0.2%
in 2015
All-time low
0.2%
in 2015
Years of data
10
2015–2024
Hepatitis B surface antigen (HBsAg) prevalence in Libya, 2015–2024
Source: World Health Organization, Global Health Observatory.
Analysis
Libya recorded 0.2% for hepatitis b surface antigen (hbsag) prevalence in 2024. That is the highest value across all 10 years on record.
The figure is unchanged over ten years.
Over the whole period, hepatitis b surface antigen (hbsag) prevalence in Libya peaked at 0.2% in 2015 and was at its lowest, 0.2%, in 2015.
Libya ranks 82nd of 194 countries on this measure, in the middle of the range.
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 0.2% | 0.2% | 0.2% | 5 |
| 2020s | 0.2% | 0.2% | 0.2% | 5 |
Countries ranked near Libya
- 82 Tajikistan 0.2% compare
- 82 Saint Vincent and the Grenadines 0.2% compare
- 82 Venezuela 0.2% compare
- 82 Antigua and Barbuda 0.2% compare
- 82 Bahamas 0.2% compare
- 82 Barbados 0.2% compare
- 82 Dominica 0.2% compare
- 82 Fiji 0.2% compare
- 82 Grenada 0.2% compare
- 82 India 0.2% compare
- 82 Jamaica 0.2% compare
- 82 Kazakhstan 0.2% compare
- 82 Saint Kitts and Nevis 0.2% compare
- 82 Saint Lucia 0.2% compare
- 82 Maldives 0.2% compare
- 82 North Macedonia 0.2% compare
- 82 Nepal 0.2% compare
- 82 Pakistan 0.2% compare
More health data for Libya
- Un projection of annual infant deaths 133 (2100)
- Heat deaths vs projected death rates 1,084 (2090)
- Deaths in armed conflicts by country 0 (2026)
- Deaths in armed conflicts by region 0 (2026)
- Age population, age 08, male, interpolated 70,474 (2025)
- Population, male 50.8% (2025)
- Age population, age 06, female, interpolated 64,590 (2025)
- Age population, age 06, male, interpolated 68,143 (2025)
- Age population, age 07, female, interpolated 65,669 (2025)
- Age population, age 07, male, interpolated 69,260 (2025)
Frequently asked questions
- What is hepatitis b surface antigen (hbsag) prevalence in Libya?
- Hepatitis b surface antigen (hbsag) prevalence in Libya was 0.2% in 2024, according to World Health Organization, Global Health Observatory.
- What is the highest hepatitis b surface antigen (hbsag) prevalence recorded in Libya?
- The highest recorded value was 0.2% in 2015.
- What is the lowest hepatitis b surface antigen (hbsag) prevalence recorded in Libya?
- The lowest recorded value was 0.2% in 2015.
- How does Libya rank for hepatitis b surface antigen (hbsag) prevalence?
- Libya ranks 82nd out of 194 countries with data for 2024.
- Is hepatitis b surface antigen (hbsag) prevalence rising or falling in Libya?
- Over the last ten years it is unchanged. The long-run trend across the full record is flat.
- Where does this Libya data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 10 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).